Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,821 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05724836Recruiting
Carotid artery narrowing treatment follow-up at clinic
This study follows people who are getting a procedure for carotid artery narrowing at the clinic. It aims to learn about outcomes after these treatments.
Jacksonville, FloridaAges 18 years+ - NCT05481697Recruiting
Track weight changes and check with a cancer blood test
This study looks at whether closely tracking small, unplanned weight loss—along with a one-time blood test (Galleri)—can help find cancer earlier. It may help people who notice changes in weight without knowing why.
Cleveland, OhioAges 40–80 - NCT04823897RecruitingPhase 1
Testing CCI-001 alone and with chemo for recurrent solid tumors
This early study tests whether CCI-001 can be given safely and may help shrink or control recurrent or metastatic (advanced) solid cancers. It checks the right dose first, then studies CCI-001 with standard chemotherapy in certain cancer types.
Edmonton, AlbertaAges 18 years+ - NCT05515484RecruitingPhase 2
Test inflatable bag to help lungs work better when prone
This Phase 2 study tests whether using an inflatable air bag can improve how well the lungs stretch and work for people with ARDS while they are lying face-down (prone) on a ventilator. If you qualify, the study may help determine whether this positioning support improves breathing and lung comfort.
AmiensAges 18 years+ - NCT02914808Recruiting
Study for leg swelling caused by lymph or vein problems
This trial studies how to measure and possibly treat swelling in the legs caused by long-term lymph or vein blockage (primary or secondary lymphoedema, or PTS). It’s looking at people with one type of leg swelling in one leg, and it checks whether MRI scans can be used safely.
Grenoble, IsèreAges 18–99 - NCT05530057RecruitingPhase 2
Eribulin plus or minus trastuzumab for HER2-positive breast cancer
This trial tests whether adding trastuzumab to eribulin improves outcomes for people with HER2-positive breast cancer that has come back or spread. It’s meant for patients whose cancer has progressed after prior HER2 and chemotherapy treatments.
SeoulAges 18 years+ - NCT05263960RecruitingPhase 1/Phase 2
CM350 drug study for advanced solid tumors
This trial tests CM350 in people with advanced solid cancers that are hard to treat with standard options. It may help by finding a safe dose and whether the drug can work against these cancers.
Chengdu, SichuanAges 18–75 - NCT05193240Recruiting
Swallowing test to predict vocal cord paralysis after lung surgery
This study checks whether a simple swallowing test can forecast vocal cord paralysis after lung surgery, compared with a camera exam of the throat. If predictions are accurate, it may help doctors prevent or plan treatment for swallowing and voice problems.
RouenAges 18 years+ - NCT02142946Recruiting
Track balance and walking in people with MS
This study measures how well you can balance and walk over time. It may help researchers understand balance problems in multiple sclerosis and how they change with movement.
BaselAges 18–80 - NCT05290662Recruiting
Patient registry for people treated with oNKord®
This trial is a registry that collects information from people who received at least one dose of oNKord® in a clinical study. It may help researchers better understand what happens after treatment and support future research.
HanoverAges 18 years+ - NCT04918173RecruitingPhase 3
Atenativ for people with inherited low antithrombin during surgery or birth
This trial tests whether Atenativ (an antithrombin treatment) lowers dangerous blood clots during planned surgery or during late pregnancy/delivery. It’s for people with a rare inherited blood-clotting condition called congenital antithrombin deficiency.
Washington D.C., District of ColumbiaAges 12–80 - NCT05062317RecruitingPhase 2
Blood test-guided chemotherapy after liver tumor removal
This trial uses a blood test (ctDNA, a sign of cancer cells shedding into the blood) to help guide chemotherapy after surgery to remove colorectal liver metastases. It may help patients get the right chemotherapy plan after their operation, potentially based on whether cancer material is still detectable.
Houston, TexasAges 18 years+ - NCT01668082Recruiting
Study brain tumor metabolism during planned brain surgery
This study looks at how brain tumors use energy (“metabolism”) during planned surgical removal. It may help researchers learn what makes tumors grow and how to improve future brain tumor treatments.
Dallas, TexasAges 18 years+ - NCT05458934Recruiting
Breath test study for adults with lung or airway conditions
This study analyzes breath samples from adults with lung or airway problems. It may help researchers understand these conditions better by looking at what’s in your exhaled breath.
Zurich, Canton of ZurichAges 18 years+ - NCT05609097Recruiting
Exercise program study for older adults with weaker heart pumping
This study tests a new exercise program for people over 65 with heart failure where the heart pumps less efficiently. The goal is to see if tailored exercise is safe and helpful for breathing, energy, and daily function.
Charlottesville, VirginiaAges 65 years+ - NCT04755387RecruitingPhase 4
Lower-dose blood thinner after heart attack stent
This trial looks at whether switching to a “lower-intensity” blood thinner plan after a heart attack and stent is safer and still works well. It may help reduce bleeding risk compared with a stronger approach, while protecting the stent from clots.
BusanAges 19–80 - NCT05445154RecruitingPhase 1/Phase 2
New treatment for newly diagnosed FLT3 AML with oral drugs
This Phase 1/2 study tests SKLB1028 (with daunorubicin and cytarabine) in people with newly diagnosed acute myeloid leukemia (AML) who have an FLT3 mutation. It aims to see how well and how safely this treatment works for this specific type of AML.
ChengduAges 18–59 - NCT04876742Recruiting
Wheat beer to help prevent confusion in ICU patients
This study tests whether drinking wheat beer can lower the risk of delirium, a sudden confusion that can happen in intensive care. If you’re at higher risk and can take the study drink safely, this could help you avoid or reduce delirium.
BaselAges 18 years+ - NCT05017051Recruiting
Testing brain function in adults with cerebral palsy
This trial measures how the brain and movement systems work in real-life (everyday) conditions. It may help researchers understand brain-related thinking and control problems in adults, and to compare them with healthy adults.
ClamartAges 18 years+ - NCT05027828Recruiting
Blood test may track ovarian cancer treatment response
This study checks whether a blood test (ctDNA) can show how well ovarian, fallopian tube, or primary peritoneal cancer treatment is working. If the test reliably reflects response, it could help doctors adjust treatment earlier and more precisely.
ShanghaiAges 18 years+ - NCT04738708Recruiting
Phone vs in-person genetic counseling for cancer risk
This study compares two ways of getting genetic counseling—by phone/video or in person—for people who may have hereditary cancer syndromes like HBOC or Lynch syndrome. It may help find which counseling approach works best for understanding results and next steps.
SingaporeAges 21 years+ - NCT05223608Recruiting
Study of people starting immunotherapy for solid tumors
This study follows people who are starting their first immune “checkpoint” treatment for a solid cancer. It collects clinic information and lab results to understand how patients respond and what factors matter most.
Lille, Hauts-de-FranceAges 18 years+ - NCT04093466RecruitingPhase 1
Testing a new pill for advanced solid tumors
This Phase 1 trial tests kanitinib (CX1003), a new cancer medicine, in people with advanced solid tumors that have come back or stopped responding to standard treatment. The goal is to find a safe dose and see early signs of tumor response.
Beijing, Beijing MunicipalityAges 18 years+ - NCT03850418RecruitingPhase 2
Azacitidine for blood chimerism changes after transplant
This Phase 2 study tests whether azacitidine can improve outcomes when donor blood “chimerism” starts dropping after an allogeneic stem cell transplant. It’s for people with AML, MDS, MPN, or CMML who are experiencing early warning signs in their blood counts after transplant but without clear relapse in the bone marrow.
Detroit, MichiganAges 18–75
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,821 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.